These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1152 related articles for article (PubMed ID: 19149089)
1. [The role of anti-cyclic citrullinated peptide (anti-CCP) antibodies in serologic diagnosis and evaluation of disease activity in rheumatoid arthritis]. Aridoğan BC; Kaya S; Savaş S; Cetin ES; Akkuş S; Demirci M Mikrobiyol Bul; 2008 Oct; 42(4):669-74. PubMed ID: 19149089 [TBL] [Abstract][Full Text] [Related]
2. Association of anti-cyclic citrullinated peptide antibodies, anti-citrullin antibodies, and IgM and IgA rheumatoid factors with serological parameters of disease activity in rheumatoid arthritis. Greiner A; Plischke H; Kellner H; Gruber R Ann N Y Acad Sci; 2005 Jun; 1050():295-303. PubMed ID: 16014545 [TBL] [Abstract][Full Text] [Related]
3. [Cyclic citrullinated peptide antibodies (anti-CCP) together with some other parameters used for serologic diagnosis of rheumatoid arthritis]. Us D; Gülmez D; Hasçelik G Mikrobiyol Bul; 2003; 37(2-3):163-70. PubMed ID: 14593899 [TBL] [Abstract][Full Text] [Related]
4. Synovial fluid levels of anti-cyclic citrullinated peptide antibodies and IgA rheumatoid factor in rheumatoid arthritis, psoriatic arthritis, and osteoarthritis. Caspi D; Anouk M; Golan I; Paran D; Kaufman I; Wigler I; Levartovsky D; Litinsky I; Elkayam O Arthritis Rheum; 2006 Feb; 55(1):53-6. PubMed ID: 16463412 [TBL] [Abstract][Full Text] [Related]
5. Diagnostic utility of anti-cyclic citrullinated peptide antibodies for very early rheumatoid arthritis. Matsui T; Shimada K; Ozawa N; Hayakawa H; Hagiwara F; Nakayama H; Sugii S; Ozawa Y; Tohma S J Rheumatol; 2006 Dec; 33(12):2390-7. PubMed ID: 16924694 [TBL] [Abstract][Full Text] [Related]
6. Determination of anti-cyclic citrullinated peptide antibodies in the sera of patients with juvenile idiopathic arthritis. Low JM; Chauhan AK; Kietz DA; Daud U; Pepmueller PH; Moore TL J Rheumatol; 2004 Sep; 31(9):1829-33. PubMed ID: 15338508 [TBL] [Abstract][Full Text] [Related]
7. Role of anticyclic citrullinated peptide in the diagnosis of early rheumatoid factor-negative suspected rheumatoid arthritis: is it worthwhile to order the test? Panchagnula R; Rajiv SR; Prakash J; Chandrashekara S; Suresh KP J Clin Rheumatol; 2006 Aug; 12(4):172-5. PubMed ID: 16891919 [TBL] [Abstract][Full Text] [Related]
8. Anti-cyclic citrullinated peptide antibodies distinguish hepatitis B virus (HBV)-associated arthropathy from concomitant rheumatoid arthritis in patients with chronic HBV infection. Lim MK; Sheen DH; Lee YJ; Mun YR; Park M; Shim SC J Rheumatol; 2009 Apr; 36(4):712-6. PubMed ID: 19286846 [TBL] [Abstract][Full Text] [Related]
9. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Schellekens GA; Visser H; de Jong BA; van den Hoogen FH; Hazes JM; Breedveld FC; van Venrooij WJ Arthritis Rheum; 2000 Jan; 43(1):155-63. PubMed ID: 10643712 [TBL] [Abstract][Full Text] [Related]
10. [Diagnostic value of serum anti-cyclic citrullinated peptide antibodies in patients with rheumatoid arthritis]. Yang CL; Zhou YR; Zhou F; Li J Nan Fang Yi Ke Da Xue Xue Bao; 2007 Aug; 27(8):1277-9. PubMed ID: 17715048 [TBL] [Abstract][Full Text] [Related]
11. Clinical evaluation of anti-mutated citrullinated vimentin by ELISA in rheumatoid arthritis. Soós L; Szekanecz Z; Szabó Z; Fekete A; Zeher M; Horváth IF; Dankó K; Kapitány A; Végvári A; Sipka S; Szegedi G; Lakos G J Rheumatol; 2007 Aug; 34(8):1658-63. PubMed ID: 17611988 [TBL] [Abstract][Full Text] [Related]
12. Diagnostic and clinical value of anti-cyclic citrullinated peptide antibodies compared with rheumatoid factor isotypes in rheumatoid arthritis. Vallbracht I; Rieber J; Oppermann M; Förger F; Siebert U; Helmke K Ann Rheum Dis; 2004 Sep; 63(9):1079-84. PubMed ID: 15308516 [TBL] [Abstract][Full Text] [Related]
14. Rheumatoid factor and antibodies to cyclic citrullinated Peptide differentiate rheumatoid arthritis from undifferentiated polyarthritis in patients with early arthritis. Jansen AL; van der Horst-Bruinsma I; van Schaardenburg D; van de Stadt RJ; de Koning MH; Dijkmans BA J Rheumatol; 2002 Oct; 29(10):2074-6. PubMed ID: 12375314 [TBL] [Abstract][Full Text] [Related]
15. Anti-CCP2 is an adjunct to, not a surrogate for, rheumatoid factor in the diagnosis of rheumatoid arthritis: diagnostic utility of anti-CCP2 antibodies in Egyptian patients with rheumatoid arthritis. Abdel-Nasser AM; Mahmoud MH; El Mansoury TM; Osman AM Scand J Rheumatol; 2008; 37(5):329-36. PubMed ID: 18666028 [TBL] [Abstract][Full Text] [Related]
16. Anti-CCP antibody test predicts the disease course during 3 years in early rheumatoid arthritis (the Swedish TIRA project). Kastbom A; Strandberg G; Lindroos A; Skogh T Ann Rheum Dis; 2004 Sep; 63(9):1085-9. PubMed ID: 15308517 [TBL] [Abstract][Full Text] [Related]
17. [Predictive values of anti-cyclic citrullinated peptide antibody, antikeratin antibody and rheumatoid factor in diagnosing articular erosions in patients with rheumatoid arthritis]. Xie QB; Yin G Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 May; 40(3):508-12. PubMed ID: 19627016 [TBL] [Abstract][Full Text] [Related]
18. Anti-cyclic citrullinated peptide (CCP) antibodies in patients with long-standing rheumatoid arthritis and their relationship with extra-articular manifestations. Korkmaz C; Us T; Kaşifoğlu T; Akgün Y Clin Biochem; 2006 Oct; 39(10):961-5. PubMed ID: 16979149 [TBL] [Abstract][Full Text] [Related]
19. Low frequency of anticyclic citrullinated peptide antibodies in psoriatic arthritis but not in cutaneous psoriasis. Candia L; Marquez J; Gonzalez C; Santos AM; Londoño J; Valle R; Zabaleta J; Yaqub Z; Espinoza LR J Clin Rheumatol; 2006 Oct; 12(5):226-9. PubMed ID: 17023808 [TBL] [Abstract][Full Text] [Related]
20. Anti-cyclic citrullinated antibodies: complementary to IgM rheumatoid factor in the early diagnosis of rheumatoid arthritis. Solanki K; Spellerberg M; Chapman P; Moller P; O'Donnell J N Z Med J; 2004 Oct; 117(1203):U1097. PubMed ID: 15477921 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]